InvestLog
IMMX logo

IMMX

Immix Biopharma, Inc.NASDAQHealthcare
$8.94+3.71%ClosedMarket Cap: $473.5M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-30HC Wainwright & Co.—Buy—
2026-03-30Mizuho—Outperform—
2026-03-27Citizens—Market Outperform—
2025-12-09HC Wainwright & Co.—Buy—
2025-09-12HC Wainwright & Co.—Buy—
2025-06-04HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.95$62.4M2
Sun Dec 31$-0.21$205.5M2
Mon Dec 31$0.43$332.1M1
Tue Dec 31$1.82$481.6M1